Asia Pacific Blood Collection Devices Market Forecast to 2030 - Regional Analysis - by Product, Methods, and End User

The Asia Pacific blood collection devices market is expected to grow from US$ 2.02 billion in 2022 to US$ 3.31 billion by 2030. It is estimated to grow at a CAGR of 6.4% from 2022 to 2030.

Rising Incidences of Chronic Diseases Boosts Asia Pacific Blood Collection Devices Market

Blood collection devices are used for drawing blood from the veins. According to the World Health Organization, the most noncommunicable disease-related deaths are cardiovascular diseases, accounting for ∼17 million people each year, followed by cancers, chronic respiratory diseases, and diabetes (including deaths associated with the kidney). Furthermore, the needles are used for drawing blood for cholesterol testing as high cholesterol can cause heart stroke and heart attack.

According to the World Heart Federation, high cholesterol causes 4.4 million deaths yearly, and ∼24% of cardiovascular-related deaths are attributable to high low-density lipoprotein (LDL) cholesterol. Further, diabetes is a life-threatening chronic disease with no practical cure. Diabetes can lead to several complications in different body parts and increase the probability of premature death. Heart attack, kidney failure, stroke, vision loss, leg amputation, and nerve damage are the major complications associated with diabetes. As per the International Diabetes Federation (IDF), in 2021, ∼537 million adults suffered from diabetes worldwide. The number is anticipated to reach 643 million and 783 million by 2030 and 2045, respectively. The treatment of chronic diseases requires blood tests and long-term medications; hence, the growing incidence of chronic diseases is anticipated to create numerous growth opportunities for the market players in the coming years.

Asia Pacific Blood Collection Devices Market Overview

The Asia Pacific blood collection devices market is expected to register the highest CAGR during the forecast period. The projected growth of the market in the coming years is attributed to the high prevalence of cancer, diabetes, and cardiovascular disease; government initiatives to boost the medical device industry; and increasing capacity of medical device manufacturing facilities in Asia Pacific countries.

Asia Pacific Blood Collection Devices Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Blood Collection Devices Market Segmentation

The Asia Pacific blood collection devices market is segmented into product type, methods, end user, and country.

Based on product type, the Asia Pacific blood collection devices Market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held the largest share of the Asia Pacific blood collection devices market in 2022.

In terms of methods, the Asia Pacific blood collection devices Market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger share of the Asia Pacific blood collection devices market in 2022.

By end user, the Asia Pacific blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held the largest share of the Asia Pacific blood collection devices market in 2022.

Based on country, the Asia Pacific blood collection devices market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated Asia Pacific blood collection devices market in 2022.

Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, and Greiner Bio One International GmBH are some of the leading companies operating in the Asia Pacific blood collection devices market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific blood collection devices market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific blood collection devices market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the blood collection devices market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution